+1 347 708 0418
Artificial Cardiopulmonary Machine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Artificial Cardiopulmonary Machine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Single Roller Pump HLM
Double Roller Pump HLM
Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
By Company
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Artificial Cardiopulmonary Machine Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Cardiopulmonary Machine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Market by Application
1.3.1 Global Artificial Cardiopulmonary Machine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Artificial Cardiopulmonary Machine Sales Estimates and Forecasts 2017-2028
2.2 Global Artificial Cardiopulmonary Machine Revenue Estimates and Forecasts 2017-2028
2.3 Global Artificial Cardiopulmonary Machine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Artificial Cardiopulmonary Machine Sales by Region
2.4.1 Global Artificial Cardiopulmonary Machine Sales by Region (2017-2022)
2.4.2 Global Sales Artificial Cardiopulmonary Machine by Region (2023-2028)
2.5 Global Artificial Cardiopulmonary Machine Revenue by Region
2.5.1 Global Artificial Cardiopulmonary Machine Revenue by Region (2017-2022)
2.5.2 Global Artificial Cardiopulmonary Machine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Artificial Cardiopulmonary Machine Sales by Manufacturers
3.1.1 Global Top Artificial Cardiopulmonary Machine Manufacturers by Sales (2017-2022)
3.1.2 Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artificial Cardiopulmonary Machine in 2021
3.2 Global Artificial Cardiopulmonary Machine Revenue by Manufacturers
3.2.1 Global Artificial Cardiopulmonary Machine Revenue by Manufacturers (2017-2022)
3.2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Artificial Cardiopulmonary Machine Revenue in 2021
3.3 Global Artificial Cardiopulmonary Machine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Artificial Cardiopulmonary Machine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Artificial Cardiopulmonary Machine Sales by Type
4.1.1 Global Artificial Cardiopulmonary Machine Historical Sales by Type (2017-2022)
4.1.2 Global Artificial Cardiopulmonary Machine Forecasted Sales by Type (2023-2028)
4.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
4.2 Global Artificial Cardiopulmonary Machine Revenue by Type
4.2.1 Global Artificial Cardiopulmonary Machine Historical Revenue by Type (2017-2022)
4.2.2 Global Artificial Cardiopulmonary Machine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
4.3 Global Artificial Cardiopulmonary Machine Price by Type
4.3.1 Global Artificial Cardiopulmonary Machine Price by Type (2017-2022)
4.3.2 Global Artificial Cardiopulmonary Machine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Artificial Cardiopulmonary Machine Sales by Application
5.1.1 Global Artificial Cardiopulmonary Machine Historical Sales by Application (2017-2022)
5.1.2 Global Artificial Cardiopulmonary Machine Forecasted Sales by Application (2023-2028)
5.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
5.2 Global Artificial Cardiopulmonary Machine Revenue by Application
5.2.1 Global Artificial Cardiopulmonary Machine Historical Revenue by Application (2017-2022)
5.2.2 Global Artificial Cardiopulmonary Machine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
5.3 Global Artificial Cardiopulmonary Machine Price by Application
5.3.1 Global Artificial Cardiopulmonary Machine Price by Application (2017-2022)
5.3.2 Global Artificial Cardiopulmonary Machine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Artificial Cardiopulmonary Machine Market Size by Type
6.1.1 North America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
6.1.2 North America Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
6.2 North America Artificial Cardiopulmonary Machine Market Size by Application
6.2.1 North America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
6.2.2 North America Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
6.3 North America Artificial Cardiopulmonary Machine Market Size by Country
6.3.1 North America Artificial Cardiopulmonary Machine Sales by Country (2017-2028)
6.3.2 North America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Artificial Cardiopulmonary Machine Market Size by Type
7.1.1 Europe Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
7.1.2 Europe Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
7.2 Europe Artificial Cardiopulmonary Machine Market Size by Application
7.2.1 Europe Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
7.2.2 Europe Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
7.3 Europe Artificial Cardiopulmonary Machine Market Size by Country
7.3.1 Europe Artificial Cardiopulmonary Machine Sales by Country (2017-2028)
7.3.2 Europe Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Artificial Cardiopulmonary Machine Market Size by Type
8.1.1 Asia Pacific Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
8.1.2 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
8.2 Asia Pacific Artificial Cardiopulmonary Machine Market Size by Application
8.2.1 Asia Pacific Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
8.2.2 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
8.3 Asia Pacific Artificial Cardiopulmonary Machine Market Size by Region
8.3.1 Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2017-2028)
8.3.2 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Artificial Cardiopulmonary Machine Market Size by Type
9.1.1 Latin America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
9.1.2 Latin America Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
9.2 Latin America Artificial Cardiopulmonary Machine Market Size by Application
9.2.1 Latin America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
9.2.2 Latin America Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
9.3 Latin America Artificial Cardiopulmonary Machine Market Size by Country
9.3.1 Latin America Artificial Cardiopulmonary Machine Sales by Country (2017-2028)
9.3.2 Latin America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Artificial Cardiopulmonary Machine Market Size by Type
10.1.1 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
10.2 Middle East and Africa Artificial Cardiopulmonary Machine Market Size by Application
10.2.1 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
10.3 Middle East and Africa Artificial Cardiopulmonary Machine Market Size by Country
10.3.1 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 LivaNova (Sorin)
11.1.1 LivaNova (Sorin) Corporation Information
11.1.2 LivaNova (Sorin) Overview
11.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 LivaNova (Sorin) Recent Developments
11.2 Getinge (Maquet)
11.2.1 Getinge (Maquet) Corporation Information
11.2.2 Getinge (Maquet) Overview
11.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Getinge (Maquet) Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medtronic Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medtronic Recent Developments
11.4 Terumo CV Group
11.4.1 Terumo CV Group Corporation Information
11.4.2 Terumo CV Group Overview
11.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Terumo CV Group Recent Developments
11.5 Braile Biomedica
11.5.1 Braile Biomedica Corporation Information
11.5.2 Braile Biomedica Overview
11.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Braile Biomedica Recent Developments
11.6 Tianjin Medical
11.6.1 Tianjin Medical Corporation Information
11.6.2 Tianjin Medical Overview
11.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tianjin Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Artificial Cardiopulmonary Machine Industry Chain Analysis
12.2 Artificial Cardiopulmonary Machine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artificial Cardiopulmonary Machine Production Mode & Process
12.4 Artificial Cardiopulmonary Machine Sales and Marketing
12.4.1 Artificial Cardiopulmonary Machine Sales Channels
12.4.2 Artificial Cardiopulmonary Machine Distributors
12.5 Artificial Cardiopulmonary Machine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Artificial Cardiopulmonary Machine Industry Trends
13.2 Artificial Cardiopulmonary Machine Market Drivers
13.3 Artificial Cardiopulmonary Machine Market Challenges
13.4 Artificial Cardiopulmonary Machine Market Restraints
14 Key Findings in The Global Artificial Cardiopulmonary Machine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Artificial Cardiopulmonary Machine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Single Roller Pump HLM
Table 3. Major Manufacturers of Double Roller Pump HLM
Table 4. Global Artificial Cardiopulmonary Machine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Artificial Cardiopulmonary Machine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Artificial Cardiopulmonary Machine Sales by Region (2017-2022) & (K Units)
Table 7. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2022)
Table 8. Global Artificial Cardiopulmonary Machine Sales by Region (2023-2028) & (K Units)
Table 9. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2023-2028)
Table 10. Global Artificial Cardiopulmonary Machine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2017-2022)
Table 12. Global Artificial Cardiopulmonary Machine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2023-2028)
Table 14. Global Artificial Cardiopulmonary Machine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Artificial Cardiopulmonary Machine Sales Share by Manufacturers (2017-2022)
Table 16. Global Artificial Cardiopulmonary Machine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers (2017-2022)
Table 18. Artificial Cardiopulmonary Machine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Artificial Cardiopulmonary Machine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Artificial Cardiopulmonary Machine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Cardiopulmonary Machine as of 2021)
Table 21. Artificial Cardiopulmonary Machine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Artificial Cardiopulmonary Machine Product Offered
Table 23. Date of Manufacturers Enter into Artificial Cardiopulmonary Machine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 26. Global Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 27. Global Artificial Cardiopulmonary Machine Sales Share by Type (2017-2022)
Table 28. Global Artificial Cardiopulmonary Machine Sales Share by Type (2023-2028)
Table 29. Global Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Artificial Cardiopulmonary Machine Revenue Share by Type (2017-2022)
Table 32. Global Artificial Cardiopulmonary Machine Revenue Share by Type (2023-2028)
Table 33. Artificial Cardiopulmonary Machine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Artificial Cardiopulmonary Machine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 36. Global Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 37. Global Artificial Cardiopulmonary Machine Sales Share by Application (2017-2022)
Table 38. Global Artificial Cardiopulmonary Machine Sales Share by Application (2023-2028)
Table 39. Global Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Artificial Cardiopulmonary Machine Revenue Share by Application (2017-2022)
Table 42. Global Artificial Cardiopulmonary Machine Revenue Share by Application (2023-2028)
Table 43. Artificial Cardiopulmonary Machine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Artificial Cardiopulmonary Machine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 46. North America Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 47. North America Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 50. North America Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 51. North America Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 54. North America Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 55. North America Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (US$ Million)
Table 105. LivaNova (Sorin) Corporation Information
Table 106. LivaNova (Sorin) Description and Major Businesses
Table 107. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. LivaNova (Sorin) Recent Developments
Table 110. Getinge (Maquet) Corporation Information
Table 111. Getinge (Maquet) Description and Major Businesses
Table 112. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Getinge (Maquet) Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Getinge (Maquet) Recent Developments
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Major Businesses
Table 117. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Medtronic Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Medtronic Recent Developments
Table 120. Terumo CV Group Corporation Information
Table 121. Terumo CV Group Description and Major Businesses
Table 122. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Terumo CV Group Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Terumo CV Group Recent Developments
Table 125. Braile Biomedica Corporation Information
Table 126. Braile Biomedica Description and Major Businesses
Table 127. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Braile Biomedica Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Braile Biomedica Recent Developments
Table 130. Tianjin Medical Corporation Information
Table 131. Tianjin Medical Description and Major Businesses
Table 132. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Tianjin Medical Artificial Cardiopulmonary Machine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tianjin Medical Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Artificial Cardiopulmonary Machine Distributors List
Table 138. Artificial Cardiopulmonary Machine Customers List
Table 139. Artificial Cardiopulmonary Machine Market Trends
Table 140. Artificial Cardiopulmonary Machine Market Drivers
Table 141. Artificial Cardiopulmonary Machine Market Challenges
Table 142. Artificial Cardiopulmonary Machine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Cardiopulmonary Machine Product Picture
Figure 3. Global Artificial Cardiopulmonary Machine Market Share by Type in 2021 & 2028
Figure 3. Single Roller Pump HLM Product Picture
Figure 4. Double Roller Pump HLM Product Picture
Figure 5. Global Artificial Cardiopulmonary Machine Market Share by Application in 2021 & 2028
Figure 6. Cardiac Surgery
Figure 7. Lung Transplant Operation
Figure 8. Acute Respiratory Failure Treatment
Figure 9. Others
Figure 10. Artificial Cardiopulmonary Machine Report Years Considered
Figure 11. Global Artificial Cardiopulmonary Machine Sales 2017-2028 (K Units)
Figure 12. Global Artificial Cardiopulmonary Machine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Artificial Cardiopulmonary Machine Revenue 2017-2028 (US$ Million)
Figure 14. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2022)
Figure 16. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2023-2028)
Figure 17. North America Artificial Cardiopulmonary Machine Sales YoY (2017-2028) & (K Units)
Figure 18. North America Artificial Cardiopulmonary Machine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Artificial Cardiopulmonary Machine Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Artificial Cardiopulmonary Machine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Artificial Cardiopulmonary Machine Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Artificial Cardiopulmonary Machine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Artificial Cardiopulmonary Machine Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Artificial Cardiopulmonary Machine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Artificial Cardiopulmonary Machine Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Artificial Cardiopulmonary Machine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Artificial Cardiopulmonary Machine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Artificial Cardiopulmonary Machine in the World: Market Share by Artificial Cardiopulmonary Machine Revenue in 2021
Figure 29. Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 31. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 32. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 33. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 34. North America Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 35. North America Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 36. North America Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 37. North America Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 38. North America Artificial Cardiopulmonary Machine Sales Share by Country (2017-2028)
Figure 39. North America Artificial Cardiopulmonary Machine Revenue Share by Country (2017-2028)
Figure 40. United States Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 43. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 45. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Artificial Cardiopulmonary Machine Sales Share by Country (2017-2028)
Figure 47. Europe Artificial Cardiopulmonary Machine Revenue Share by Country (2017-2028)
Figure 48. Germany Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 49. France Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Artificial Cardiopulmonary Machine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Artificial Cardiopulmonary Machine Revenue Share by Region (2017-2028)
Figure 59. China Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 62. India Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Artificial Cardiopulmonary Machine Sales Share by Country (2017-2028)
Figure 73. Latin America Artificial Cardiopulmonary Machine Revenue Share by Country (2017-2028)
Figure 74. Mexico Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Artificial Cardiopulmonary Machine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Share by Country (2017-2028)
Figure 83. Turkey Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Artificial Cardiopulmonary Machine Revenue (2017-2028) & (US$ Million)
Figure 86. Artificial Cardiopulmonary Machine Value Chain
Figure 87. Artificial Cardiopulmonary Machine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Buy
